This federal contract award, worth $1,112.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,753,381 units of Spironolactone 25mg tablets, a cardiovascular medication, with a completion date of December 19, 2024.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's extensive capabilities in supplying a diverse portfolio of essential medical commodities to federal agencies, particularly the DLA, which oversees the procurement of medical products for the U.S. military and veterans' healthcare systems.
Generated 3/19/25, 9:50 AM